早产儿脑静脉窦血栓形成
本研究为回顾性连续队列研究,纳入26例经影像学确诊脑静脉窦血栓形成的早产儿(胎龄<37周),分析其临床与影像特征、治疗及结局。结果显示73%有症状,横窦(85%)与上矢状窦(42%)常见,脑实质损伤以脑室周围(35%)和深部白质(31%)为主,46%发生脑室内出血,69%接受抗凝治疗且无治疗后新发或加重出血,随访时50%无缺陷、25%轻中度、25%重度损害。作者认为该小队列中抗凝治疗看似安全,需更大规模研究。
要点
- 早产儿脑静脉窦血栓形成中73%有症状,超过四分之一无症状。
- 血栓常见于横窦(85%)和上矢状窦(42%),脑实质损伤以脑室周围和深部白质为主。
- 69%接受抗凝治疗,无治疗后新发或加重出血;随访50%无缺陷、25%轻中度、25%重度损害。
核心结论
- 在该早产儿脑静脉窦血栓形成样本中,超过四分之一无症状,白质脑病变为主,随访时一半有神经功能缺陷。
- 该小队列中早产儿脑静脉窦血栓形成的抗凝治疗看似安全,需更大规模研究。
研究设计与样本
- 回顾性连续队列研究,纳入26例胎龄<37周、经影像学确诊脑静脉窦血栓形成的早产儿。
- 重新审阅所有磁共振成像/磁共振静脉成像和CT/CT静脉成像扫描,以研究血栓特征和脑损伤模式。
- 采用经验证的儿童卒中结局量表在最近一次门诊随访时评估结局。
主要发现
- 65%为中度至晚期早产儿(32-37周),27%为极早产儿(28-32周),8%为超早产儿(<28周)。
- 73%就诊时有症状,表现为癫痫发作或查体异常。
- 横窦(85%)和上矢状窦(42%)为常见血栓部位;脑实质损伤主要位于脑室周围(35%)和深部白质(31%)。
- 46%发生脑室内出血;69%接受抗凝治疗,无治疗患儿(包括11例治疗前出血者)出现治疗后新发或加重出血。
- 结局为无缺陷50%、轻中度损害25%、重度损害25%。
局限性
- 该队列样本量小。
- 需更大规模的早产儿脑静脉窦血栓形成研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neonatal cerebral venous sinus thrombosis (CVST) can lead to brain injury and neurodevelopmental impairments. Previous studies of neonatal CVST have focused on term infants, and studies of preterm infants are lacking. In this study, we examined the clinical and radiological features, treatment and outcome of CVST in preterm infants. METHODS: This was a retrospective, consecutive cohort study of preterm infants (gestational age <37 weeks) with radiologically confirmed CVST. All magnetic resonance imaging/MRV and CT/CTV scans were re-reviewed to study thrombus characteristics and pattern of brain injury. Outcome was assessed by the validated pediatric stroke outcome measure at the most recent clinic visit. RESULTS: Twenty-six preterm infants with CVST were studied. Of these, 65% were moderate-late preterm (32-37 weeks), 27% very preterm (28-32 weeks), and 8% extreme preterm (<28 weeks). Most (73%) were symptomatic at presentation with seizures or abnormal exam. Transverse (85%) and superior sagittal (42%) sinuses were common sites of thrombosis. Parenchymal brain injury was predominantly periventricular (35%) and deep white matter (31%) in location. Intraventricular hemorrhage occurred in 46%. Most infants (69%) were treated with anticoagulation. No treated infant (including eleven with pretreatment hemorrhage) had new or worsening post-treatment hemorrhage. Outcomes ranged from no deficits (50%), mild-moderate (25%), and severe (25%) impairment. CONCLUSIONS: In our sample of preterm infants with CVST, more than one-quarter were asymptomatic. White matter brain lesions predominated and one-half had neurological deficits at follow-up. Anticoagulation of preterm CVST in this small cohort appeared to be safe. Larger studies of preterm CVST are needed.
引用
- Christensen R, Krishnan P, deVeber G, et al. Cerebral Venous Sinus Thrombosis in Preterm Infants. Stroke. 2022. PMID: 35430899. doi:10.1161/STROKEAHA.121.037621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。